PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26984766-5	2016	RESULTS: Immunoreactivity of the autophagy-associated markers, beclin 1 and LC3, in carcinoma cells increased in 14% and 52% of the patients, respectively, following the exemestane treatment.	exemestane	170-180	microtubule associated protein 1 light chain 3 alpha	Homo sapiens	76-79	
26984766-11	2016	CONCLUSIONS: Results of our present study demonstrated that beclin 1 and LC3 immunoreactivity increased in carcinoma cells following exemestane treatment and that the status of pre-treatment stromal beclin 1 is associated with higher carcinoma cell proliferation and poor clinical and pathological responses to NAE.	exemestane	133-143	microtubule associated protein 1 light chain 3 alpha	Homo sapiens	73-76